Cancel
Known information
- Received his medical degree and doctorate in immunology from the University of Cape Town
- Completed his master of business administration from the University of Michigan
- Completed his internal medicine training and fellowship in immunology at Groote Schuur Hospital and associated teaching hospitals in Cape Town, South Africa
- Previously served as Senior Vice President and Development Head for Pfizer Neuroscience
- Was Worldwide Head of Clinical Research and Development at Pfizer
- Held the position of Vice President of Exploratory Development for the Midwest region, based in Ann Arbor, Mich., at Pfizer
- Was Head of Experimental Medicine at Pfizer’s Sandwich, UK Laboratories
About Eliem Therapeutics
Eliem Therapeutics is a biopharmaceutical company focused on developing therapies for neuronal excitability disorders, with key projects including ETX-155 for major depressive disorder and focal onset seizures.
Report inaccurate information
